Abstract
Human granulocyte-macrophage colony-stimulating factor (hGM-CSF) activates a set of genes such as c-fos, jun, myc, and early growth response gene 1 (egr-1). Studies on BA/F3 cells that express hGM-CSF receptor (hGMR) showed that two different signaling pathways controlled by distinct regions within the beta subunit are involved in activation of c-fos/c-jun genes and in c-myc, respectively. However, the region(s) of the beta subunit responsible for activation of the egr-1 gene and other regulatory genes has not been identified. We describe here how egr-1 promoter is activated by hGMR through two regions of the beta subunit, with these regions being required for activation of the c-fos promoter. Coexpression of dominant negative (dn) Ras (N17ras) or dn JAK2 almost completely suppressed the activation of egr-1 and c-fos promoters. Deletion analysis of egr-1 promoter showed two cis-acting regions responsible for activation by hGM-CSF or mouse interleukin-3 (mIL-3), one between nucleotide positions (nt) -56 and -116, and the other between nt -235 and -480, which contains tandem repeats of the serum response element (SRE) sites. Similar experiments with the c-fos promoter showed that cis-acting regions containing the SRE/AP-1 sites is sufficient for activation by hGM-CSF. Based on these observations, we propose that signaling pathways activating egr-1 and c-fos promoters are controlled by SRE elements, either through the same or overlapping pathways that involve JAK2 and Ras.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Binding Sites
-
Cell Line
-
DNA-Binding Proteins / biosynthesis
-
DNA-Binding Proteins / genetics*
-
Early Growth Response Protein 1
-
Enzyme Inhibitors / pharmacology
-
Gene Expression Regulation / drug effects*
-
Genes, fos*
-
Genes, ras
-
Genistein
-
Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
-
Hematopoietic Stem Cells / drug effects*
-
Hematopoietic Stem Cells / physiology
-
Humans
-
Immediate-Early Proteins*
-
Interleukin-4 / pharmacology
-
Isoflavones / pharmacology
-
Janus Kinase 1
-
Janus Kinase 2
-
Mice
-
Promoter Regions, Genetic*
-
Protein-Tyrosine Kinases / physiology
-
Proto-Oncogene Proteins c-fos / biosynthesis
-
Proto-Oncogene Proteins p21(ras) / physiology
-
Proto-Oncogene Proteins*
-
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / chemistry
-
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / drug effects
-
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / physiology*
-
Recombinant Proteins / pharmacology
-
Signal Transduction / physiology*
-
Transcription Factors / biosynthesis
-
Transcription Factors / genetics*
Substances
-
DNA-Binding Proteins
-
EGR1 protein, human
-
Early Growth Response Protein 1
-
Egr1 protein, mouse
-
Enzyme Inhibitors
-
Immediate-Early Proteins
-
Isoflavones
-
Proto-Oncogene Proteins
-
Proto-Oncogene Proteins c-fos
-
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
-
Recombinant Proteins
-
Transcription Factors
-
Interleukin-4
-
Granulocyte-Macrophage Colony-Stimulating Factor
-
Genistein
-
Protein-Tyrosine Kinases
-
JAK1 protein, human
-
JAK2 protein, human
-
Jak1 protein, mouse
-
Jak2 protein, mouse
-
Janus Kinase 1
-
Janus Kinase 2
-
HRAS protein, human
-
Proto-Oncogene Proteins p21(ras)